Survey: One-Third of Adults Say Cannabis Helps Them Sleep
- A survey by the American Academy of Sleep Medicine found that 33% of respondents reported cannabis helps them sleep or improves their sleep quality.
- While 47% of respondents do not use cannabis for sleep, 11% said it had no impact, and 8% experienced worse sleep from cannabis use.
- Women were less likely to use cannabis for sleep (55% reported no use) compared to men (39%), and men (39%) were more likely to report better sleep from cannabis than women (28%).
- The survey, conducted with 2,007 U.S. adults in June 2025, highlights that cannabis's impact on sleep is complex, with potential risks including daytime sleepiness, impaired driving, dependence, and withdrawal symptoms.
A survey published this month from the American Academy of Sleep Medicine (AASM) found that 33% of respondents report cannabis helps them sleep or provides them with significantly better sleep. The 2025 Sleep Prioritization Survey, released June 1, found 11% of respondents said cannabis had no impact on their sleep, with 8% reporting significantly or slightly worse sleep, while 47% of respondents said they did not use cannabis to help them sleep.
In a statement, AASM past president Dr. Kannan Ramar noted that while medical and adult-use cannabis programs are more common in the U.S., cannabis’s “impact on sleep is multi-faceted.”
“Use of marijuana and other cannabis products is also associated with several clinical concerns, including increased risks of daytime sleepiness, impaired driving performance, physical dependence, and withdrawal symptoms such as sleep disruption.” — Ramar in a press release
Over half of women surveyed – 55% – reported no cannabis use, compared with 39% of men. Additionally, 39% of men reported sleeping better due to cannabis use, compared with 28% of women. Respondents between the ages of 25 and 44 years were most likely to report a beneficial effect of cannabis on sleep (45%), while older adults were less likely to report using cannabis.
The survey included 2,007 adults in the U.S. and was conducted by independent research agency, Atomik Research, between June 5 and June 13, 2025.